Although Il-17A and IL-17F are known to signal through the same receptor IL-17RA/RC, the results obtained here from the analysis indicate that IL-17F and not IL-17A was significantly enriched in the plasma of patients with severe COVID-19. The gene discussed is IL17RA; the disease is COVID-19.